Nutex Health, Inc. NUTX
We take great care to ensure that the data presented and summarized in this overview for Nutex Health, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding NUTX
View all-
Highbridge Capital Management LLC New York, NY33.6MShares$19.2 Million0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA13MShares$7.39 Million0.0% of portfolio
-
One Plus One Wealth Management, LLC5.29MShares$3.02 Million0.29% of portfolio
-
Black Rock Inc. New York, NY4.61MShares$2.63 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.37MShares$2.49 Million0.0% of portfolio
-
Truist Financial Corp4.37MShares$2.49 Million0.0% of portfolio
-
Scissortail Wealth Management, LLC Tulsa, OK2.2MShares$1.25 Million0.06% of portfolio
-
Gds Wealth Management1.11MShares$632,7290.01% of portfolio
-
Pensionmark Financial Group, LLC Santa Barbara, CA1.03MShares$585,1830.02% of portfolio
-
Beaird Harris Wealth Management, LLC Dallas, TX780KShares$444,6430.01% of portfolio
Latest Institutional Activity in NUTX
Top Purchases
Top Sells
About NUTX
Nutex Health, Inc. operates as a technology-enabled healthcare services company. It operates through two divisions: Hospital division and Population Health Management division. The Hospital division implements and operates health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 21 facilities in 8 states. The Population Health Management division owns and operates provider networks, such as independent physician associations. Its management services organizations provide management, administrative, and other support services to its affiliated hospitals and physician groups. This division's cloud-based proprietary technology platform aggregates data across multiple information systems, settings, and sources to create a holistic view of each patient and provider, as well as allows to deliver care. The company is based in Houston, Texas.
Insider Transactions at NUTX
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 12
2024
|
Joshua De Tillio Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+40.54%
|
$0
$0.54 P/Share
|
|
May 30
2024
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
2,986
+0.02%
|
$0
$0.66 P/Share
|
|
May 29
2024
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
3,768
+0.02%
|
$0
$0.68 P/Share
|
|
May 28
2024
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
48,394
+0.27%
|
$0
$0.7 P/Share
|
|
May 13
2024
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
17,330
+0.1%
|
$0
$0.69 P/Share
|
|
Mar 12
2024
|
Jon Christian Bates Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
49,505
+26.26%
|
-
|
|
Mar 12
2024
|
Pamela W. Montgomery Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,502
+26.83%
|
-
|
|
Nov 20
2023
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
275,200
+0.1%
|
$0
$0.23 P/Share
|
|
Nov 17
2023
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
224,800
+0.08%
|
$0
$0.23 P/Share
|
|
Nov 15
2023
|
Joshua De Tillio Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
140,000
+50.0%
|
$0
$0.24 P/Share
|
|
Sep 22
2023
|
Warren Hosseinion President |
SELL
Bona fide gift
|
Direct |
141,000
-56.7%
|
-
|
|
Aug 31
2023
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
152,326
+0.06%
|
$0
$0.28 P/Share
|
|
Aug 30
2023
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
305,947
+0.11%
|
$0
$0.31 P/Share
|
|
Aug 29
2023
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
342,744
+0.13%
|
$0
$0.3 P/Share
|
|
Aug 28
2023
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
198,983
+0.07%
|
$0
$0.28 P/Share
|
|
Jun 15
2023
|
Jon Christian Bates Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+18.26%
|
$0
$0.42 P/Share
|
|
Jun 14
2023
|
Mitchell Creem Director |
BUY
Open market or private purchase
|
Indirect |
50,000
+37.95%
|
$0
$0.43 P/Share
|
|
Jun 14
2023
|
Pamela W. Montgomery Chief Legal Officer |
BUY
Open market or private purchase
|
Direct |
12,000
+29.63%
|
$0
$0.43 P/Share
|
|
Jun 13
2023
|
Cheryl Yvonne Grenas Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+50.0%
|
$0
$0.43 P/Share
|
|
Jun 13
2023
|
Michael Lee Reed Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+50.0%
|
$0
$0.43 P/Share
|
Last 12 Months Summary
| Open market or private purchase | 1.73M shares |
|---|---|
| Exercise of conversion of derivative security | 66K shares |
| Bona fide gift | 141K shares |
|---|